中国科技核心期刊
美国《化学文摘》CAS数据库收录
日本科学技术振兴机构数据库收录
湖北省优秀期刊
中国知网网络首发期刊

Current Issue

  • 2026 Volume 21 Issue 10
    Published: 25 October 2026
      

  • Select all
    |
  • ZHANG Huie1, XIAO Mengli1, JI Jinjin1, CHENG Yurong2, LU Fang1
    PDF ( )   Knowledge map   Save
    Objective: To screen Alzheimer’s disease (AD) biomarkers using GEO (Gene Expression Omnibus) database combined with machine learning. Methods: A total of 339 samples were included, including 168 AD samples and 171 samples from normal healthy people. The GEO database screened the datasets to derive the differentially expressed genes, screened the predictive gene models by two algorithms: least absolute shrinkage and selection operator (LASSO) logistic regression and random forest (RF), and plotted ROC curves to evaluate the models. Clinical datasets (including multiple groups of AD patients and healthy control samples) were used to validate the predicted genes. RT-qPCR quantitatively analyzed the expression of the predicted genes in the normal and model groups of the AD cell model. Result: LASSO yielded 84 key markers, and RF algorithm identified 7 genes. Venn diagram screening yielded overlapping genes for 2 algorithms, including PLSCR4, GLIS3, PHYHD1, and HVCN1. ROC curves in the test set showed that the area under the curve of these 4 candidate genes was greater than 0.7, and ROC curves in the validation set also showed that the area under the curve of 3 of these candidates was greater than 0.7, among which GLIS3 (AUC=0.891) and HVCN1 (AUC=0.953) exhibited excellent diagnostic performance (AUC>0.89). The RT-qPCR method revealed that the relative expression of PLSCR4, GLIS3, PHYHD1 and HVCN1 was elevated in the AD cell model compared with the normal control group (all P<0.01), and the results were consistent with the bioinformatic predictions. Conclusion: PLSCR4, GLIS3, PHYHD1 and HVCN1 may be used as molecular markers for clinical diagnosis of AD.
  • LI Jiarong, ZHANG Ying, ZHU Lili, SONG Liang, YU Meng, LI Haoran, FU Shengqi
    PDF ( )   Knowledge map   Save
    Objective: To investigate the efficacy and safety of ultra-early tirofiban administration in patients with branch atheromatous disease (BAD) who show no relief of neurological deficit symptoms after intravenous thrombolysis. Methods: A retrospective analysis was conducted on patients admitted to the Stroke Center of Zhengzhou People’s Hospital from January 2021 to December 2024, who met the diagnostic criteria for BAD, completed intravenous thrombolysis but had no symptomatic relief. According to whether they received ultra-early tirofiban treatment, the patients were divided into a tirofiban group and a control group. Patients were followed up to 90 days, the modified Rankin Scale (mRS) was used to evaluate their long-term clinical prognosis, symptomatic intracranial hemorrhage, other adverse events and deaths were recorded, and the efficacy and safety of the two groups were compared. Results: A total of 130 patients were enrolled, including 62 in the tirofiban group and 68 in the control group. The National Institute of Health Stroke Scale (NIHSS) scores of the tirofiban group at 24~72 h and 7 days after treatment were lower than those of the Control group [3 (2,5) vs 3 (3,6), 2 (1,4) vs 3 (2,4)], and the proportions of patients with mRS score ≤1 and mRS score ≤2 at 90 days in the tirofiban group were higher than those in the control group (66.13% vs 42.65%, 72.58% vs 54.41%), with statistically significant differences (all P<0.05). One patient in the tirofiban group developed symptomatic intracranial hemorrhage, while no symptomatic intracranial hemorrhage occurred in the control group. In terms of death events, 2 patients in the tirofiban group died, with the causes being pneumonia and pulmonary embolism secondary to deep vein thrombosis detachment after long-term bed rest respectively; 1 patient in the Control group died of post-stroke pulmonary infection. The incidence of other adverse events was 11.29% in the tirofiban group and 7.35% in the Control group, and statistical analysis showed no significant differences (all P>0.05). Conclusion: For patients with BAD who have no symptomatic relief after intravenous thrombolysis, ultra-early application of tirofiban can significantly improve the prognosis with relatively high safety.
  • WANG Ye, ZHOU Yuanyuan
    PDF ( )   Knowledge map   Save
    Objective: To analyze the associated influencing factors and optimal cut-off values of electromyogram (EMG) abnormalities in patients with type 2 diabetes mellitus (T2DM). Methods: A total of 131 T2DM patients undergoing initial EMG examinations were enrolled. Patients were divided into a normal EMG group (N-EMG, 64 cases) and an abnormal EMG group (EMG, 67 cases). General data and clinical indicators were compared between the two groups. Logistic regression analysis was used to identify risk factors for EMG abnormalities in T2DM. The diagnostic performance and cut-off values of these factors were assessed using receiver operating characteristic (ROC) curves. Additionally, patients were stratified into high urinary protein (H-UPr) and low urinary protein (L-UPr) groups based on 24-hour urinary protein levels, and differences in EMG abnormality rates and characteristics were compared. Results: Significant differences in age, diabetes duration, diastolic blood pressure, pulse pressure, fasting blood glucose (FBG), glycated hemoglobin (HbA1c), free triiodothyronine (FT3), free thyroxine (FT4), FT3/FT4 ratio, D-dimer, and 24-hour urinary protein (24 h-UPr) were observed between the EMG and N-EMG groups (all P<0.05). Logistic regression analysis revealed that age, HbA1c, and 24 h-UPr were independent risk factors for EMG abnormalities in T2DM (all P<0.05). The combined model of these three factors demonstrated an area under the curve (AUC) of 0.846, with sensitivity 77.42%, specificity 77.56%, and a cut-off value of 61.5 years, 8.20% HbA1c, and 71.00 mg/24h for 24 h-UPr. The EMG abnormality rate was significantly higher in the H-UPr group than in the L-UPr group (P<0.05), with predominant involvement of the tibial and fibular sensory nerves in the lower limbs (P<0.05). Conclusion: Advanced age, elevated HbA1c, and increased 24 h-UPr are independent risk factors for EMG abnormalities in T2DM. The combined detection of these three parameters enhances diagnostic efficacy, particularly when age >61.5 years, HbA1c >8.20%, or 24 h-UPr >71.00 mg/24h.
  • ZHU Chunran1, ZHANG Hongbo2, LIAN Zehao3, LI Yuntao4, CHEN Xingyuan5, HUANG Boyuan6, CHEN Lin6, TANG Zhouping7
    PDF ( )   Knowledge map   Save
    Objective: Addressing the limitations of existing treatments for hemifacial spasm and post-facial paralysis sequelae, to establish a standardized technical system for percutaneous stylomastoid foramen facial nerve radiofrequency modulation that integrates multimodal imaging guidance with electrophysiological verification, and to elucidate its indications, operational procedures, and safety. Methods: The “triple guidance” technique was adopted: (1) Preoperative thin-section CT three-dimensional reconstruction of the stylomastoid foramen and planning of the puncture path; (2) Intraoperative ultrasound (with color Doppler used to avoid blood vessels) or real-time DSA guidance to puncture to the main trunk of the facial nerve at the stylomastoid foramen; (3) Individualized electrophysiological localization-for patients with mild to moderate functional impairment, low-current (0.3-0.8 mA) nerve trunk functional localization was performed, while for those with severe facial paralysis, anatomical localization was prioritized and verified by electrical stimulation. In terms of treatment, pulsed radiofrequency (42 ℃, 120-180 seconds) modulation or continuous radiofrequency (50-70 ℃) moderate ablation was selected, with abnormal muscle response monitoring (amplitude reduction >50%) and facial symmetry used to determine the therapeutic endpoint. In May 2026, this technique was applied to 6 consecutive patients (5 females, 53-72 years old; 2 cases of hemifacial spasm, 3 cases of Bell's palsy, and 1 case of Hunt syndrome, 6 cases in total). Results: All 6 patients underwent the surgery successfully with no complications. Improvement in House-Brackmann (H-B) grading was observed: 3 cases progressed from Ⅲ to Ⅱ, 1 case from Ⅳ to Ⅱ, and 1 case from Ⅴ to Ⅳ. The median Sunnybrook score increased from 46 to 64.5, with 1 case showing marked improvement and 5 cases showing effectiveness. In HFS patients, the amplitude of abnormal muscle response decreased progressively, and postoperative spasms were immediately relieved. No postoperative persistent worsening of facial paralysis, hematoma, infection, or hearing impairment occurred; only 2 patients experienced temporary mild facial weakness, which improved by discharge. The duration of a single procedure ranged from 20 to 35 minutes. Conclusion: The “triple guidance” percutaneous stylomastoid foramen facial nerve radiofrequency modulation technique achieves dual localization of imaging anatomy and electrophysiological function. It is standardized, reproducible, minimally invasive, and safe, providing a minimally invasive alternative for refractory HFS and filling the gap in neuromodulation treatment for post-facial paralysis sequelae. Its long-term efficacy still requires verification through large-sample and long-term follow-up studies.
  • ZHUANG Aolin1,2, CHEN Juan1, QU Wensheng2, LIU Na2
    PDF ( )   Knowledge map   Save
    Objective: Based on relevant guidelines from the National Medical Products Administration, this study aims to advance the new drug registration process for Zhixuan Analgesic Tablets and systematically summarize its human use experience in treating tension-type headache (TTH), providing evidence-based support for new drug development and clinical promotion. Methods: A prospective real-world study design was employed, enrolling 250 TTH patients. Patients were administered oral Zhixuan Analgesic Tablets (4 tablets per dose, 3 times daily) for a continuous 12-week intervention. The primary efficacy outcome was the number of monthly headache days; secondary outcomes included response rate, acute analgesic usage days, Visual Analog Scale (VAS) scores, and Headache Impact Test-6 (HIT-6) scores. Safety was also assessed. Results: Of 250 enrolled patients, 232 completed intention-to-treat analysis. Compared with baseline, at the third month of intervention, the mean monthly headache days significantly decreased [(3.63±4.41) days vs. (10.76±3.59) days, P<0.05], with a clinical response rate of 71.55%. Secondary outcomes, including acute analgesic usage days, average/peak VAS scores, and HIT-6 scores, all showed significant reductions compared with baseline (P<0.05). The overall incidence of adverse events during the study was 7.6% (19/250), primarily mild gastrointestinal reactions (5.6%) and mild dizziness (2.21%), with no severe adverse events reported. Conclusion: Real-world evidence indicates that Zhixuan Analgesic Tablets significantly reduce headache frequency, alleviate pain intensity, decrease acute analgesic use, and improve quality of life in TTH patients. The favorable safety profile supports its potential for new drug conversion and clinical implementation.
  • XIANG Aojie, LIN Guan, SUN Xia, WANG Li, WANG Xiaoping, LIU Shana, LI Tingyi
    PDF ( )   Knowledge map   Save
    Acute large vessel occlusion represents a severe subtype of acute ischemic stroke (AIS), and endovascular treatment serves as the optimal approach to restore reperfusion. However, a substantial proportion of patients, up to 44%-52%, still experience poor functional outcomes despite successful recanalization, a phenomenon termed "futile recanalization," which has emerged as a critical bottleneck limiting clinical benefits. This article systematically reviews the latest advances in the evolving definition, incidence, underlying pathophysiological mechanisms, and predictive factors of futile recanalization. The core definition of futile recanalization is established as successful vascular recanalization (mTICI grade ≥2b) yet a 3-month mRS score of 3-6. Its mechanisms are closely linked to microcirculatory disturbances and involve multiple processes, including the no-reflow phenomenon, early arterial reocclusion, poor collateral circulation, hemorrhagic transformation, blood-brain barrier disruption, and reperfusion injury. Predictive factors encompass clinical characteristics such as age, NIHSS score, atrial fibrillation, and diabetes, as well as imaging markers and postoperative complications, including cerebral atrophy, white matter lesions, collateral circulation status, contrast extravasation, and malignant brain edema. Currently, the pathophysiological mechanisms underlying futile recanalization remain incompletely elucidated, and a standardized early prediction system is lacking. Future research should focus on constructing multidimensional dynamic prediction models, optimizing patient selection and perioperative management, improving tissue perfusion while achieving efficient recanalization, and ultimately enhancing the conversion rate to favorable functional outcomes following endovascular treatment.
  • HUANG Siyu1,2,3,4,LIANG Rongxiang1,2,3,4,WANG Yue1,2,3,4
    PDF ( )   Knowledge map   Save
    Progressive non-fluent aphasia (PNFA) is a neurodegenerative disease, a clinical subtype of primary progressive aphasia, characterized by gradually slowing, intermittent language expression and increasing grammatical errors. Current studies have shown that PNFA is mainly associated with abnormalities in tau protein and TAR DNA binding protein-43 (TDP-43), and may involve multiple protein pathologies. In terms of diagnosis, researchers have used imaging techniques such as magnetic resonance imaging (MRI), positron emission tomography (PET), and radiomics to discover specific brain structural changes in patients with PNFA, providing a basis for early diagnosis. In terms of treatment, speech and language therapy and non-invasive brain stimulation techniques (such as transcranial direct current stimulation and transcranial magnetic stimulation) have shown certain improvement effects, but the progress of pharmacotherapy is currently limited.
  • ZHANG Haipei, WANG Zhuoran, BAI Shangkai, GUO Junhong
    PDF ( )   Knowledge map   Save
    With the intensification of population aging, the prevalence of cognitive disorders is increasing year by year, and the early identification of high-risk populations holds significant clinical implications. Insulin resistance (IR) is a common pathological feature of cognitive aging and dementia. The triglyceride-glucose (TyG) index, a novel IR marker proposed in recent years, is calculated based on fasting blood glucose and triglycerides. Compared with the insulin resistance index, it has advantages such as a broader applicable population, higher standardization of detection, and more stable and reliable results. This article reviews the predictive value of the TyG index for cognitive disorders: multiple studies have confirmed that a higher TyG index is associated with an increased risk of dementia and cognitive impairment (CI) in the general population. It is a good predictor of mild cognitive impairment in patients with type 2 diabetes and is independently associated with vascular cognitive impairment in patients with cerebral small vessel disease and post-stroke cognitive impairment. Its potential mechanisms involve reduced brain glucose metabolism, cerebral vascular hypoperfusion, metabolic disorders caused by IR, as well as Aβ deposition and excessive tau protein phosphorylation. However, most of the existing studies are cross-sectional in design, making it difficult to clarify causal relationships. Moreover, cognitive assessment tools and cut-off values are inconsistent, and there may be gender differences in predictive efficacy. As a simple, economical, and reliable marker of IR, the TyG index has potential clinical value in the early identification and risk assessment of cognitive disorders. Future research with large samples and long-term follow-up is still needed to validate its predictive efficacy and explore the value of its combined application with other metabolic indicators.
  • WANG Mingyue1,WANG Shilin1,2,LI Jiaohui1,SUN Yuanzheng2
    PDF ( )   Knowledge map   Save
    Neuropathic pain (NP) is a type of pain directly caused by damage or disease of the somatosensory system. It severely impairs patients’ sleep and quality of life, and triggers more severe anxiety and depressive symptoms, making it difficult for patients to achieve a favorable prognosis. As a safe and effective complementary and alternative therapy, acupuncture demonstrates unique advantages in the treatment of NP. Integrating cutting-edge research findings from both domestic and international sources, this paper takes functional magnetic resonance imaging (fMRI) technology as the entry point, systematically explores the central mechanisms of neuropathic pain, and conducts a detailed analysis of the specific effects of acupuncture in treating this condition, aiming to provide a solid theoretical foundation for the clinical promotion and application of acupuncture for NP.
  • WANG Xinhui1,ZHANG Jiameng1,LIU Genli1,2
    PDF ( )   Knowledge map   Save
    Perinatal depression (PND) refers to mood disorders that occur during pregnancy and within one year after childbirth, which seriously affect the physical and mental health of mothers as well as the early development of infants. Although traditional psychological interventions and pharmacological treatments have certain therapeutic effects, they still face limitations such as poor accessibility, slow onset of action, and significant side effects. Non-invasive neuromodulation techniques are characterized by non-invasiveness, precision, and safety, with minimal side effects on both mothers and infants, making them particularly suitable for the treatment of PND. Currently, neuromodulation techniques represented by transcranial magnetic stimulation (TMS) and transcranial electrical stimulation (TES) have accumulated certain clinical evidence. By modulating the prefrontal-limbic system circuits, promoting neuroplasticity, and other multiple mechanisms, they have demonstrated good efficacy in alleviating depressive symptoms and improving cognitive functions. In recent years, with the development of emerging models such as individualized stimulation protocols, deep brain modulation techniques, and closed-loop brain-computer interfaces, neuromodulation therapy is evolving towards precision, synergy, and systemization. This article mainly reviews the clinical application and mechanisms of action of non-invasive neuromodulation techniques in the treatment of PND, aiming to provide a theoretical basis and reference for clinical practice and subsequent research.
  • MAO Zhangqi1,WEI Feng2,QIAN Guo3,XU Jiao4,CHANG Liying4
    PDF ( )   Knowledge map   Save
    Acute unilateral vestibulopathy (AUVP) is a relatively common type of vertigo disorder characterized by acute, unilateral functional impairment of the peripheral vestibular system. Studies have found that vestibular functional impairment in AUVP patients exhibits frequency selectivity, manifesting as greater susceptibility of high-frequency function to damage with relatively rapid recovery, while low-frequency functional damage is comparatively difficult to recover from. Examination methods such as caloric testing, sinus harmonic rotational chair testing, and video head impulse testing can assess the functional status of different frequency bands within patients' vestibular system. This article reviews the frequency characteristics of the vestibular system, the clinical application of vestibular function examination methods across different frequencies, as well as the characteristics of frequency-selective damage and recovery patterns during the disease course of AUVP, aiming to provide a theoretical basis for developing individualized diagnosis and treatment strategies for AUVP patients.
  • WANG Lei1,SHI Siyao1,WANG Xin1,DU Miao2,JIANG Ying1
    PDF ( )   Knowledge map   Save
    Extensive studies have shown that childhood trauma is a significant risk factor for the development of alcohol use disorder. This article explores the mechanisms associated with childhood trauma and alcohol use disorder from three dimensions: physiological, psychological, and social. At the physiological level, it involves changes in the endocrine system and brain development; at the psychological level, it involves emotional regulation disorders and maladaptive coping mechanisms; and at the social level, it involves family environment and the lack of social support systems. This review aims to systematically explore the correlation between childhood trauma and alcohol use disorder, analyze its underlying mechanisms, and provide healthcare professionals with a basis for formulating targeted clinical intervention measures.